Oryzon to present at upcoming international conferences


• 11th Clinical Trials on Alzheimer's Disease, CTAD-2018, Barcelona, Spain

• European Alzheimer’s Disease Consortium meeting, Barcelona, Spain

• 24th Annual International Partnering Conference BIO-Europe-2018, Copenhagen, Denmark

• Jefferies London Healthcare Conference, London, UK

• 2018 Citi Global Healthcare Conference, New York, USA

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of Oryzon will present at several international reputed conferences in October and November 2018.


Click here to see the full Press Release